The word "recall" is a source of discomfort for many CEOs and compliance leaders. But it's a reality of doing business, especially in the food industry. The Peanut Corporation of America's 2008 Salmonella recall, which resulted in the deaths of nine people and the closure of the company, is a case in point. In this presentation, you'll learn how to navigate a recall, whether it's necessary to avoid one or to handle one effectively. We'll discuss the fundamentals of product recalls, including:
How to identify potential recalls
How to develop a recall plan
How to communicate with your customers during a recall
How to dispose of recalled products
We'll also discuss the difference between a recall and a market withdrawal, and how to avoid the pitfalls of both. So, if you're responsible for food safety at your company, this presentation is for you.
Click here to download Speaker Presentation
How to identify potential recalls
How to develop a recall plan
How to communicate with your customers during a recall
How to dispose of recalled products
We'll also discuss the difference between a recall and a market withdrawal, and how to avoid the pitfalls of both. So, if you're responsible for food safety at your company, this presentation is for you.
Click here to download Speaker Presentation
Date & Time
Wednesday October 25th, 2023 1:30pm PDT
End Date & Time
Wednesday October 25th, 2023 2:00pm PDT
Location
Booth #1350
| MODERATOR |
 Amy SummersFounder & President, Pitch Publicity® & INICIVOX® Amy Summers founded Pitch Publicity® in 2003, securing billions of earned media impressions for 100 natural product companies. In 2020, she launched INICIVOX®, an education platform that enhances communication skills. A pioneer in virtual mentorship, Summers has earned CSR, DEI, and education awards from PR News and Nutrition Business Journal and is a PR News Top Women Awards Honoree in business entrepreneurship. |
| SPEAKERS |
| Heather Fairman CEO, DF Guardian Consulting Inc. Heather N. D. Fairman is founder and CEO of DF Guardian Consulting, Inc. and has over 30 years in executive leadership and management experience in regulatory affairs, quality assurance (QA) and quality control (QC) environments in the dietary supplement, food and beverage, biologic, over-the-counter (OTC) pharmaceutical and cosmetic industries. She is a sought-after independent consultant, transformational thought leader, writer and certified go-to speaker, educator and trainer, who also serves as the key technical advisor responsible for leading the development of raw materials for the herbal supply-chain market for the SIDS (Small Island Developing States) DOCK Island Women Open Network (IWON), an intergovernmental organization which has all the rights and privileges of a United Nations organization comprised of 32 countries. Heather has assisted and led companies through numerous FDA inspections, assisted with FDA 483 responses, averted recalls and warning letters, and established effective and sustainable compliance and organizational programs that have fostered mutually beneficial contract manufacturer partnerships. Her keen ability to foster effective supply chain compliance solutions that increase businesses' bottom lines strategically positions her to provide operational input, support and results-driven outcomes for emerging and existing food supply technology systems. Fairman also holds Food Safety Preventive Control Alliance (FSPCA) certificates as a Lead Instructor for Preventive Controls for Human Food (PCHF) and Lead Instructor for the Foreign Supplier Verification Program (FSVP). Heather can be contacted at: hfairman@dfguardianconsulting.com; https://www.linkedin.com/in/heather-duncan-fairman-43425b1a2/ |
| Marc Ullman Of Counsel, Rivkin Radler Marc S. Ullman represents clients in matters relating to all aspects of FDA regulatory issues with a focus on the dietary supplement/natural products industry; FTC proceedings and litigation concerning consumer protection compliance and response to enforcement actions concerning advertising practices, privacy and cyber security. Previously, he practiced with one of New York’s leading white collar criminal defense firms for ten years, where he represented clients in both federal and state prosecutions, as well as numerous related civil matters and other litigations. Marc’s practice as part of the firm’s Health Services Practice Group includes representation of clients on issues relating to FDA compliance, including labels, labeling, claims and good manufacturing practices. He has also represented clients in a number of complex adversarial proceedings with the FDA relating to the scope of the agency’s powers under the Dietary Supplement Health and Education Act of 1994 and its ability to seek remedies such as consumer restitution, has counseled clients on general litigation-related issues, and most recently on complex legal issues of concern to the emerging hemp trade in the United States. He has represented clients in adversarial proceedings involving FTC, including the negotiation of consent decrees and litigation regarding the adequacy of substantiation of advertising claims. Marc has appeared/testified on behalf of clients before FDA’s Food Advisory Committee and at FDA’s 2000 hearing concerning the impact of the First Amendment to the United States Constitution on FDA’s regulation of health claims concerning diseases. He has also counseled clients in connection with matters under investigation by the United States Congress. Marc’s expertise includes guiding clients through FDA’s New Dietary Ingredient (NDI) Notification Process and counseling on issues involved in achieving status as generally recognized as safe (GRAS) as a prerequisite for ingredient use in food products. His work in these areas includes counseling on the first GRAS assessment for stevia, leading to the first legal importation of this ingredient as a sweetener. He also provides counsel to clients dealing with serious recall situations. His work has included representation of clients at the heart of the pet food/melamine, StarCaps and pistachio recalls, providing advice in dealing with FDA. |
Category
FiNA Theater